Correction: Prospects and limitations of cumate-inducible lentivirus as a tool for investigating VEGF-A-mediated pathology in diabetic retinopathy

Inesa Lelyte; Vidhya R. Rao; Giedrius Kalesnykas; Symantas Ragauskas; Simon Kaja; Zubair Ahmed

doi:10.1038/s41598-025-17850-0

Correction: Prospects and limitations of cumate-inducible lentivirus as a tool for investigating VEGF-A-mediated pathology in diabetic retinopathy

Inesa Lelyte^*
, Vidhya R. Rao
, Giedrius Kalesnykas
, Symantas Ragauskas
, Simon Kaja
, Zubair Ahmed^*

^*Corresponding author for this work

Inflammation and Ageing

Research output: Contribution to journal › Comment/debate

2 Downloads (Pure)

Abstract

Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024

The original version of this Article contained an error in Figure 4, where the ‘Baseline Cumate 0.6 mg/2 μL’ panel was a duplication of the ‘3 days after IVT Control’ panel.

The original Figure 4 and accompanying legend appear below.

The original Article has been corrected.

Original language	English
Article number	32938
Number of pages	2
Journal	Scientific Reports
Volume	15
DOIs	https://doi.org/10.1038/s41598-025-17850-0
Publication status	Published - 25 Sept 2025

Bibliographical note

Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41598-025-17850-0Licence: Creative Commons: Attribution (CC BY)

LelyteI2025CorrectionFinal published version, 896 KBLicence: Creative Commons: Attribution (CC BY)

Prospects and limitations of cumate‑inducible lentivirus as a tool for investigating VEGF‑A‑mediated pathology in diabetic retinopathy
Lelyte, I., Rao, V. R., Kalesnykas, G., Ragauskas, S., Kaja, S. & Ahmed, Z., 21 Jun 2024, In: Scientific Reports. 14, 12 p., 14325.
Research output: Contribution to journal › Article › peer-review

Open Access
File
39 Downloads (Pure)

Cite this

@article{173c1701b13f45579a89df55a38e058a,

title = "Correction: Prospects and limitations of cumate-inducible lentivirus as a tool for investigating VEGF-A-mediated pathology in diabetic retinopathy",

abstract = "Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024 The original version of this Article contained an error in Figure 4, where the {\textquoteleft}Baseline Cumate 0.6 mg/2 μL{\textquoteright} panel was a duplication of the {\textquoteleft}3 days after IVT Control{\textquoteright} panel. The original Figure 4 and accompanying legend appear below. The original Article has been corrected. ",

author = "Inesa Lelyte and Rao, \{Vidhya R.\} and Giedrius Kalesnykas and Symantas Ragauskas and Simon Kaja and Zubair Ahmed",

note = "Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024",

year = "2025",

month = sep,

day = "25",

doi = "10.1038/s41598-025-17850-0",

language = "English",

volume = "15",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Correction: Prospects and limitations of cumate-inducible lentivirus as a tool for investigating VEGF-A-mediated pathology in diabetic retinopathy

AU - Lelyte, Inesa

AU - Rao, Vidhya R.

AU - Kalesnykas, Giedrius

AU - Ragauskas, Symantas

AU - Kaja, Simon

AU - Ahmed, Zubair

N1 - Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024

PY - 2025/9/25

Y1 - 2025/9/25

N2 - Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024 The original version of this Article contained an error in Figure 4, where the ‘Baseline Cumate 0.6 mg/2 μL’ panel was a duplication of the ‘3 days after IVT Control’ panel. The original Figure 4 and accompanying legend appear below. The original Article has been corrected.

AB - Correction to: Scientific Reports https://doi.org/10.1038/s41598-024-63590-y, published online 21 June 2024 The original version of this Article contained an error in Figure 4, where the ‘Baseline Cumate 0.6 mg/2 μL’ panel was a duplication of the ‘3 days after IVT Control’ panel. The original Figure 4 and accompanying legend appear below. The original Article has been corrected.

U2 - 10.1038/s41598-025-17850-0

DO - 10.1038/s41598-025-17850-0

M3 - Comment/debate

SN - 2045-2322

VL - 15

JO - Scientific Reports

JF - Scientific Reports

M1 - 32938

ER -

Correction: Prospects and limitations of cumate-inducible lentivirus as a tool for investigating VEGF-A-mediated pathology in diabetic retinopathy

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Research output

Prospects and limitations of cumate‑inducible lentivirus as a tool for investigating VEGF‑A‑mediated pathology in diabetic retinopathy

Cite this